1. Home
  2. BIO vs TFX Comparison

BIO vs TFX Comparison

Compare BIO & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • TFX
  • Stock Information
  • Founded
  • BIO 1952
  • TFX 1943
  • Country
  • BIO United States
  • TFX United States
  • Employees
  • BIO N/A
  • TFX N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • TFX Medical/Dental Instruments
  • Sector
  • BIO Industrials
  • TFX Health Care
  • Exchange
  • BIO Nasdaq
  • TFX Nasdaq
  • Market Cap
  • BIO 6.2B
  • TFX 5.3B
  • IPO Year
  • BIO N/A
  • TFX N/A
  • Fundamental
  • Price
  • BIO $220.55
  • TFX $121.38
  • Analyst Decision
  • BIO Strong Buy
  • TFX Hold
  • Analyst Count
  • BIO 4
  • TFX 10
  • Target Price
  • BIO $330.50
  • TFX $176.50
  • AVG Volume (30 Days)
  • BIO 346.2K
  • TFX 456.8K
  • Earning Date
  • BIO 07-31-2025
  • TFX 07-31-2025
  • Dividend Yield
  • BIO N/A
  • TFX 1.12%
  • EPS Growth
  • BIO N/A
  • TFX N/A
  • EPS
  • BIO N/A
  • TFX 3.20
  • Revenue
  • BIO $2,541,100,000.00
  • TFX $3,010,144,000.00
  • Revenue This Year
  • BIO N/A
  • TFX $2.88
  • Revenue Next Year
  • BIO $3.69
  • TFX $4.85
  • P/E Ratio
  • BIO N/A
  • TFX $37.97
  • Revenue Growth
  • BIO N/A
  • TFX 0.29
  • 52 Week Low
  • BIO $211.43
  • TFX $118.70
  • 52 Week High
  • BIO $387.99
  • TFX $249.91
  • Technical
  • Relative Strength Index (RSI)
  • BIO 39.53
  • TFX 41.90
  • Support Level
  • BIO $220.31
  • TFX $119.10
  • Resistance Level
  • BIO $233.28
  • TFX $123.13
  • Average True Range (ATR)
  • BIO 8.41
  • TFX 2.83
  • MACD
  • BIO -1.81
  • TFX -0.00
  • Stochastic Oscillator
  • BIO 21.38
  • TFX 25.31

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About TFX Teleflex Incorporated

Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.

Share on Social Networks: